These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. [Concurrent chemotherapy and radiation therapy for unresectable locally advanced carcinoma of the esophagus. Phase II study and clinical review on literature]. Fritz P, Stoll P, Wannenmacher M, Zierhut D. Strahlenther Onkol; 2003 May; 179(5):328-36. PubMed ID: 12740660 [Abstract] [Full Text] [Related]
9. A phase I trial of 5-fluorouracil with cisplatin and concurrent standard-dose radiotherapy in Japanese patients with stage II/III esophageal cancer. Nakajima TE, Ura T, Ito Y, Kato K, Minashi K, Nihei K, Hironaka S, Boku N, Kagami Y, Muro K. Jpn J Clin Oncol; 2009 Jan; 39(1):37-42. PubMed ID: 19103671 [Abstract] [Full Text] [Related]
10. Esophageal cancer. A prospective phase II study of concomitant-boost external-beam chemoradiation with a top-up endoluminal boost. Brunner TB, Rupp A, Melzner W, Grabenbauer GG, Sauer R. Strahlenther Onkol; 2008 Jan; 184(1):15-22. PubMed ID: 18188518 [Abstract] [Full Text] [Related]
18. Late toxicity after definitive concurrent chemoradiotherapy for thoracic esophageal carcinoma. Morota M, Gomi K, Kozuka T, Chin K, Matsuura M, Oguchi M, Ito H, Yamashita T. Int J Radiat Oncol Biol Phys; 2009 Sep 01; 75(1):122-8. PubMed ID: 19327900 [Abstract] [Full Text] [Related]